Transferring Research From Lab to Market

Fraunhofer USA, Inc., a legally independent US affiliate founded by Fraunhofer-Gesellschaft, is an R&D organization working with industry, universities, and state and federal governments on contract research projects. We are in the high-tech problem solving business; we utilize our world class scientific and engineering expertise to respond to technical problems, to design and develop prototypes, to develop and proof the manufacturing processes, to bridge the gap between basic research and market moving new developments along the technology readiness scale. These translational activities allow our customers to have a positive societal impact.

 

Learn More About How to Work with Us

Fraunhofer-Gesellschaft Latest News

3.11.2021

Stem cells from the bioreactor

With the aid of artificial stem cells, it will soon be possible to establish new treatments for previously incurable diseases such as Alzheimer’s disease. At the Fraunhofer Project Center for Stem Cell Process Engineering SPT, a process for the mass production of these so called induced pluripotent stem cells is being developed. This process involves new materials, which ensure that industrial cell production will meet high quality standards. The process will be unveiled to the public for the first time at the MEDICA trade fair in Düsseldorf, Germany, between November 15 and 18, 2021 (hall 3, stand E74).
Read more

2.11.2021

Safe, patient-friendly implants for personalized therapy

Implants can actively support the body, as in the case of pacemakers, neuro-prostheses or cochlear implants. In the future, active implants will be smaller, less energy-intensive and, above all, more patient-friendly. This is why the Fraunhofer Institute for Biomedical Engineering IBMT is working on miniaturization, external power supplies and wirelessly networked implants. The latest developments will be presented at COMPAMED/MEDICA in Düsseldorf from November 15 to 18 (Hall 13, Stand D60).
Read more

2.11.2021

Fraunhofer Institutes present the first prototype for digital twins of patients

Optimum prevention, diagnosis and treatment in just one click: As part of the “MED²ICIN” lighthouse project, seven Fraunhofer Institutes are presenting the first prototype of a digital patient model. This prototype revolutionizes the very foundation of personalized and cost-optimized treatment, opening up new perspectives. It has already been tested at University Hospital Frankfurt.
Read more

2.11.2021

From medical applications to sporting goods – biocompatible and sustainable plastics

Numerous plastic products are made of polyurethanes. Fraunhofer researchers have developed a manufacturing method for polyurethanes that avoids use of toxic isocyanates while making use of carbon dioxide as a starting material. Polyurethanes of a reproducible standard are being developed in collaboration with partners from industry. The research results can be seen from November 15 to 18 at MEDICA 2021 in Düsseldorf (hall 3, stand E74).
Read more
 

Fraunhofer USA Focus 2020

The Annual Fraunhofer USA Focus provides an in-depth

insight into the latest developments and

research at Fraunhofer USA.

Fraunhofer Media and Press

Press and Media content from Fraunhofer-Gesellschaft Headquarter in Munich 

 

Fraunhofer Media and Press

 

Fraunhofer USA

Fraunhofer USA Headquarters

44792 Helm Street

Plymouth MI, 48170 USA

Phone: +1 734-354-4335

 

Fraunhofer USA Programs

Fraunhofer USA programs help us to accomplish our mission of providing cutting edge technologies to companies and organizations of all sizes.

 

Come Meet Us

Fraunhofer USA participates in conferences and tradeshows. Please come visit us to learn more.